Carl-Erik Nord

Publications
Public outreach and news

Articles

Journal article: VALUE IN HEALTH. 2018;21(4):441-448
The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection
Kleinman L; Talbot GH; Hunsche E; Schuler R; Nord CE
Article: ANAEROBE. 2016;38:97-102
Clostridium difficile recurrences in Stockholm
Sandell S; Rashid M-U; Jorup-Ronstrom C; Ellstrom K; Nord CE; Weintraub A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(1):213-219
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection
Gerding DN; Hecht DW; Louie T; Nord CE; Talbot GH; Cornely OA; Buitrago M; Best E; Sambol S; Osmolski JR; Kracker H; Locher HH; Charef P; Wilcox M
Article: MBIO. 2015;6(6):e01693-e01615
Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces
Zaura E; Brandt BW; de Mattos MJT; Buijs MJ; Caspers MPM; Rashid M-U; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJF; Crielaard W
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(10):6266-6273
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection
Louie T; Nord CE; Talbot GH; Wilcox M; Gerding DN; Buitrago M; Kracker H; Charef P; Cornely OA
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2015;21(8):767.e1-767.e4
Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle
Dalhoff A; Rashid M-U; Kapsner T; Panagiotidis G; Weintraub A; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(8):4504-4509
Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota
Rashid M-U; Rosenborg S; Panagiotidis G; Soderberg-Lofdal K; Weintraub A; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(8):4410-4416
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor
Card RM; Mafura M; Hunt T; Kirchner M; Weile J; Rashid M-U; Weintraub A; Nord CE; Anjum MF
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2015;46(1):60-65
Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota
Rashid M-U; Rosenborg S; Panagiotidis G; Lofdal KS; Weintraub A; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 2015;60:S77-S84
Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods
Rashid M-U; Zaura E; Buijs MJ; Keijser BJF; Crielaard W; Nord CE; Weintraub A
Article: ANAEROBE. 2015;31:72-77
Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin
Rashid M-U; Weintraub A; Nord CE
Article: ANAEROBE. 2014;30:65-69
Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China
Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2014;44(2):125-130
Ecological impact of MCB3837 on the normal human microbiota
Rashid M-U; Dalhoff A; Backstrom T; Bjorkhem-Bergman L; Panagiotidis G; Weintraub A; Nord CE
Article: ANAEROBE. 2014;28:216-219
In vitro activity of MCB3681 against Clostridium difficile strains
Rashid M-U; Dalhoff A; Weintraub A; Nord CE
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2014;52(1):173-179
Toxin-Producing Clostridium difficile Strains as Long-Term Gut Colonizers in Healthy Infants
Adlerberth I; Huang H; Lindberg E; Aberg N; Hesselmar B; Saalman R; Nord CE; Wold AE; Weintraub A
Article: ANAEROBE. 2013;20:32-35
In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden
Rashid M-U; Lozano HM; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2013;41(4):352-357
Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora
Rashid M-U; Panagiotidis G; Backstrom T; Weintraub A; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(9):E347-E354
Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in Leon, Nicaragua
Amaya E; Reyes D; Paniagua M; Calderon S; Rashid M-U; Colque P; Kuhn I; Mollby R; Weintraub A; Nord CE
Article: ANAEROBE. 2012;18(2):249-253
Effect of new antimicrobial agents on the ecological balance of human microflora
Rashid M-U; Weintraub A; Nord CE
Article: PLOS ONE. 2012;7(7):e41480
An Expanded Multilocus Sequence Typing Scheme for Propionibacterium acnes: Investigation of 'Pathogenic', 'Commensal' and Antibiotic Resistant Strains
McDowell A; Barnard E; Nagy I; Gao A; Tomida S; Li H; Eady A; Cove J; Nord CE; Patrick S
Article: INFECTION. 2011;39(6):571-574
Cellulose and PapG are important for Escherichia coli causing recurrent urinary tract infection in women
Norinder BS; Luthje P; Yadav M; Kadas L; Fang H; Nord CE; Brauner A
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2011;38(6):474-479
Effect of telavancin on human intestinal microflora
Rashid M-U; Weintraub A; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2011;23(3):145-149
Comparative Effects of the Immediate and the Extended Release Formulations of Ciprofloxacin on Normal Human Intestinal Microflora
Rashid M; Weintraub A; Nord CE
Article: FEMS MICROBIOLOGY LETTERS. 2011;319(2):125-132
The role of Bacteroides fragilis RecQ DNA helicases in cell survival after metronidazole exposure
Paul L; Patrick S; Nord CE; Abratt V
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(3):371-379
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience
Nagy E; Urban E; Nord CE
Article: JOURNAL OF MEDICAL MICROBIOLOGY. 2011;60(2):216-222
Antibiotic resistance patterns of intestinal Escherichia coli isolates from Nicaraguan children
Amaya E; Reyes D; Vilchez S; Paniagua M; Mollby R; Nord CE; Weintraub A
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2010;36(6):537-541
Effect of ceftobiprole on the normal human intestinal microflora
Backstrom T; Panagiotidis G; Beck O; Asker-Hagelberg C; Rashid M-U; Weintraub A; Nord CE
Article: ANAEROBE. 2010;16(6):633-635
Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains
Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE
Article: RESEARCH IN MICROBIOLOGY. 2010;161(5):346-354
Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole
Steffens LS; Nicholson S; Paul LV; Nord CE; Patrick S; Abratt VR
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2010;54(5):1811-1814
Effect of Ceftaroline on Normal Human Intestinal Microflora
Panagiotidis G; Backstrom T; Asker-Hagelberg C; Jandourek A; Weintraub A; Nord CE
Article: APMIS. 2010;118(5):413-417
Screening for vancomycin-resistant enterococci: results of a survey in Stockholm
Fang H; Nord CE; Ullberg M
Article: JOURNAL OF CHEMOTHERAPY. 2010;22(1):25-29
Antibiotic Resistance Patterns in Gram-Negative and Gram-Positive Bacteria Causing Septicemia in Newborns in Leon, Nicaragua: Correlation with Environmental Samples
Amaya E; Caceres M; Fang H; Torres Ramirez A; Palmgren A-C; Nord CE; Weintraub A
Article: CLINICAL INFECTIOUS DISEASES. 2010;50:S16-S23
Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
Lofmark S; Edlund C; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2009;15(12):1170-1173
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm
Huang H; Fang H; Weintraub A; Nord CE
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2009;47(11):3729-3731
Comparison of a Commercial Multiplex Real-Time PCR to the Cell Cytotoxicity Neutralization Assay for Diagnosis of Clostridium difficile Infections
Huang H; Weintraub A; Fang H; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;34(3):268-270
Prevalence of qnr determinants among extended-spectrum β-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden
Fang H; Huang H; Shi Y; Hedin G; Nord CE; Ullberg M
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(6):2455-2462
P1A Recombinant β-Lactamase Prevents Emergence of Antimicrobial Resistance in Gut Microflora of Healthy Subjects during Intravenous Administration of Ampicillin
Tarkkanen A-M; Heinonen T; Jogi R; Mentula S; van der Rest ME; Donskey CJ; Kemppainen T; Gurbanov K; Nord CE
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2009;25(6):1461-1467
Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial-resistant streptococci in the microflora of healthy adults
Nord CE; Peterson J; Ambruzs M; Fisher AC
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;33(4):339-342
Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren A-C; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;33(3):272-275
In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany
Alba V; Urban E; Angeles Dominguez M; Nagy E; Nord C-E; Palacin C; Vila J
Article: NUTRITION JOURNAL. 2009;8:4
Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome
Sullivan A; Nord CE; Evengard B
Article: CURRENT INFECTIOUS DISEASE REPORTS. 2009;11(1):3-6
Can metronidazole still be used for treatment of Clostridium difficile infections?
Huang H; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2008;31(4):316-320
European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci
Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Kononen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2008;14(4):370-376
Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005
Fang H; Hedin G; Li G; Nord CE
Article: CURRENT INFECTIOUS DISEASE REPORTS. 2007;9(4):263-264
When should probiotics be used in gastrointestinal infections?
Nord CE
Article: ACTA DERMATO-VENEREOLOGICA. 2007;87(3):246-254
Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris
Oprica C; Emtestam L; Hagstromer L; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2007;13(1):106-108
Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden
Fang H; Hedin G; Telander B; Li G; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2006;28(6):497-502
Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey
Soki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2006;50(10):3375-3380
Effect of tigecycline on normal oropharyngeal and intestinal microflora
Nord CE; Sillerstrom E; Wahlund E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2006;58(3):627-631
Effect of dalbavancin on the normal intestinal microflora
Nord CE; Rasmanis G; Wahlund E
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2006;50(4):1528-1530
Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection
Norinder BS; Norrby R; Palmgren AC; Hollenberg S; Eriksson U; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2006;38(5):327-331
Probiotic lactobacilli and bacteraemia in Stockholm
Sullivan A; Nord CE
Article: ANAEROBE. 2005;11(3):137-143
Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries
Oprica C; Löfmark S; Lund B; Edlund C; Emtestam L; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2005;11(3):204-213
European surveillance study on the antibiotic susceptibility of Propionibacterium acnes
Oprica C; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2005;49(1):170-175
Ecological effects of perorally administered pivmecillinam on the normal vaginal microflora
Sullivan A; Fianu-Jonasson A; Landgren BM; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004;48(10):3765-3772
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers
Pletz MWR; Rau M; Bulitta J; De Roux A; Burkhardt O; Kruse G; Kurowski M; Nord CE; Lode H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2004;54(4):791-797
Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora
Sullivan Å; Johansson A; Svenungsson B; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2004;10(10):937-939
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
Jalal S; Nord CE; Lappalainen M; Evengård B
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2004;10(10):899-903
Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease
Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Article: ANAEROBE. 2004;10(3):155-164
Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm
Oprica C; Emtestam L; Lapins J; Borglund E; Nyberg F; Stenlund K; Lundeberg L; Sillerström E; Nord CE
Article: APMIS. 2004;112(6):342-348
DNA extraction and PCR assays for detection of Toxoplasma gondii
Edvinsson B; Jalal S; Nord CE; Pedersen BS; Evengård B
Article: JOURNAL OF CHEMOTHERAPY. 2004;16(3):227-229
In vitro activity of ABT-492 against anaerobic bacteria
Sillerström E; Wahlund E; Nord CE
Article: MICROBIAL DRUG RESISTANCE. 2004;10(3):255-263
Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections
Nord CE; Farrell DJ; Leclercq R
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2003;52(2):308-311
Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine
Sullivan Å; Barkholt L; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2003;15(3):244-247
Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin
Nord CE; Meurling L; Russo RL; Bello A; Grasela DM; Gajjar DA
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2003;9(6):475-488
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.
Hedberg M; Nord CE; ESCMID Study Group on Antimicrobial Resistance in
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2003;9(5):397-405
Anaerobic bacteria commonly colonize the lower airways of intubated ICU patients
Agvald-Öhman C; Wernerman J; Nord CE; Edlund C
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2003;9(4):306-309
Will triclosan in toothpaste select for resistant oral streptococci?
Sullivan Å; Wretlind B; Nord CE
Article: ANAEROBE. 2003;9(1):11-14
The micro-flora of the small bowel in health and disease
Sullivan Å; Törnblom H; Lindberg G; Hammarlund B; Palmgren AC; Einarsson C; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2003;9(1):65-68
Dientamoeba fragilis -: a protozoal infection which may cause severe bowel distress
Norberg A; Nord CE; Evengård B
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2002;37(12):1380-1385
Bovine anti-Helicobacter pylori antibodies for oral immunotherapy
Casswall TH; Nilsson HO; Björck L; Sjöstedt S; Xu L; Nord CE; Borén T; Wadström T; Hammarström L
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2002;50(5):707-712
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers
Burkhardt O; Borner K; von der Höh N; Köppe P; Pletz MW; Nord CE; Lode H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2002;50(5):625-627
Probiotics in human infections
Sullivan Å; Nord CE
Article: INFECTION. 2002;30(3):158-160
The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics
Bennet R; Eriksson M; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2002;8(4):229-239
Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora.
Nord CE; Gajjar DA; Grasela DM
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2002;37(2):215-221
Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice
Orrhage KM; Annas A; Nord CE; Brittebo EB; Rafter JJ
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(1):17-21
Impact of combinations of antineoplastic drugs on intestinal microflora in 9 patients with leukaemia.
Nyhlén A; Ljungberg B; Nilsson-Ehle I; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(12):898-903
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces
Burkhardt O; Borner K; Stass H; Beyer G; Allewelt M; Nord CE; Lode H
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2001;7(7):376-379
Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia.
Vogel F; Ochs HR; Wettich K; Kalich S; Nilsson-Ehle I; Odenholt I; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2001;45(6):1860-1867
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.
Livermore DM; Carter MW; Bagel S; Wiedemann B; Baquero F; Loza E; Endtz HP; van Den Braak N; Fernandes CJ; Fernandes L; Frimodt-Moller N; Rasmussen LS; Giamarellou H; Giamarellos-Bourboulis E; Jarlier V; Nguyen J; Nord CE; Struelens MJ; Nonhoff C; Turnidge J; Bell J; Zbinden R; Pfister S; Mixson L; Shungu DL
Article: JOURNAL OF CHEMOTHERAPY. 2001;13(3):299-308
Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora
Sullivan Å; Edlund C; Svenungsson B; Emtestam L; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2001;7(5):230-237
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions
Lund B; Edlund C; Rynnel-Dagöö B; Lundgren Y; Sterner J; Nord CE
Article: ANAEROBE. 2001;7(2):67-70
Effect of Lactobacillus paracasei on intestinal colonisation of lactobacilli, bifidobacteria and Clostridium difficile in elderly persons
Sullivan Å; Palmgren AC; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2001;13(1):47-51
Impact of gemifloxacin on the normal human intestinal microflora.
Barker PJ; Sheehan R; Teillol-Foo M; Palmgren AC; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2001;33(12):899-903
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora
Lode H; Von der Höh N; Ziege S; Borner K; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2001;47(1):43-50
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients:: a prospective study
Wiström J; Norrby SR; Myhre EB; Eriksson S; Granström G; Lagergren L; Englund G; Nord CE; Svenungsson B
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2000;46(5):741-749
Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora
Edlund C; Alván G; Barkholt L; Vacheron F; Nord CE
Article: INFECTION. 2000;28(5):272-277
Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone
Oh H; Nord CE; Barkholt L; Hedberg M; Edlund C
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2000;46(4):603-612
Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil
Orrhage K; Sjöstedt S; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2000;6(10):549-556
In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study.
Goering R; Nord CE; Hare R; Sabatelli F; Ziracin Susceptibility Testing Group
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2000;19(8):635-637
In vitro activity of ABT-773 against anaerobic bacteria.
Sillerström E; Wahlund E; Nord CE
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2000;19(7):548-550
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora.
Beyer G; Hiemer-Bau M; Ziege S; Edlund C; Lode H; Nord CE
Article: ANAEROBE. 2000;6(3):143-148
Prevalence and antimicrobial susceptibility of enterotoxigenic Bacteroides fragilis in children with diarrhoea in Nicaragua
Cáceres M; Zhang GM; Weintraub A; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2000;6(4):175-177
Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora
Adamson I; Edlund C; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2000;6(3):159-163
In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline.
Edlund C; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2000;32(6):627-632
Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin
Lund B; Edlund C; Barkholt L; Nord CE; Tvede M; Poulsen RL
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2000;32(1):81-85
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora
Edlund C; Beyer G; Hiemer-Bau M; Ziege S; Lode H; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2000;6(3):158-163
In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline
Edlund C; Nord CE
Article: INJURY. 1999;30(10):651-657
Material and design in haematogenous implant-associated infections in a rabbit model
Johansson A; Lindgren JU; Nord CE; Svensson O
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1999;44(5):629-640
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients
Adamsson I; Nord CE; Lundquist P; Sjöstedt S; Edlund C
Article: INJURY. 1999;30(9):587-590
Local plate infections in a rabbit model
Johansson Å; Lindgren JU; Nord CE; Svensson O
Article: ARCHIVES OF ORAL BIOLOGY. 1999;44(10):789-793
Isolation of bacteria from cervical lymph nodes in patients with oral cancer
Sakamoto H; Naito H; Ohta Y; Tanakna R; Maeda N; Sasaki J; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 1999;5(10):612-616
Association between bacterial colonization on the tumor, bacterial translocation to the cervical lymph nodes and subsequent postoperative infection in patients with oral cancer.
Sakamoto H; Sasaki J; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 1999;29(1):1-8
Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis
Hall G; Heimdahl A; Nord CE
Article: ANAEROBE. 1999;5(3-4):431-434
Identification of the metallo-β-lactamase gene from clinical isolates of Bacteroides fragilis
Fang H; Hedberg M; Edlund C; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 1999;11(2):90-92
In vitro activity of LY 333328 against anaerobic Gram-positive bacteria
Sillerström E; Wahlund E; Nord CE
Article: ANAEROBE. 1999;5(1):11-18
Characterization of β-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting
Fang H; Hedberg M; Edlund C; Jarstrand C; Fodor E; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 1999;11(1):50-53
Ecological effect of gatifloxacin on the normal human intestinal microflora
Edlund C; Nord CE
Article: TECHNICAL REPORT SERIES - WORLD HEALTH ORGANIZATION, GENEVA. 1999;888:1-95
Evaluation of certain veterinary drug residues in food -: Fiftieth report of the Joint FAO/WHO Expert Committee on Food Additives
Applegren LE; Arnold D; Boisseau J; Boobis AR; Ellis RL; Livingston RC; McLean JG; MacNeil JD; Miller MA; Miterna ES; Palermo-Neto; Pintér A; Martinez JLR; Sinhaseni P; Soback S; Wells R; Cernigilia CE; Chamberlain P; Chernausek SD; Fuchs R; Good EAM; Hansen MK; Heitzman RJ; Herrman JL; Mitsumori K; Nord CE; Olsen P; Paakkanen J; Pronk MEJ; Ritter L; Roberts G; Roestal B; Sills RC; Sundlof S; Ungemach FR; Weber N
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1998;28(11):958-965
Sudden infant death syndrome and nitrogen metabolism: further development of a hypothesis
Wiklund L; George M; Nord CE; Ronquist G; Saldeen T
Article: JOURNAL OF CLINICAL GASTROENTEROLOGY. 1998;27(2):138-142
The value of different detection methods of Helicobacter pylori during treatment
Adamsson I; Nord CE; Sjöstedt S; Wikström B; Seensalu R
Article: JOURNAL OF CHEMOTHERAPY. 1998;10(4):280-284
In vitro activity of HMR 3647 against anaerobic bacteria
Edlund C; Sillerstrom E; Wahlund E; Nord CE
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 1998;17(3):193-195
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria
Edlund C; Sabouri S; Nord CE
Article: ANAEROBE. 1998;4(1):29-33
Comparison of E test and agar dilution methods for determining antibiotic susceptibilities of anaerobic bacteria and viridans streptococci isolated from blood
Hall G; Heimdahl A; Nord CE
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1998;33(1):39-43
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin
Sjöstedt S; Sagar M; Lindberg G; Wikström B; Nord CE; Seensalu R
Article: TRANSPLANT INTERNATIONAL. 1997;10(6):432-438
Stool cultures obtained before liver transplantation are useful for choice of perioperative antibiotic prophylaxis
Barkholt LM; Andersson J; Ericzon BG; Palmgren AC; Broome U; Duraj F; Bergquist A; Herlenius G; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 1997;25(3):729-732
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy
Edlund C; Barkholt L; OlssonLiljequist B; Nord CE
Article: INFECTION. 1997;25(3):154-158
Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora
Adamsson I; Edlund C; Sjostedt S; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1997;29(4):383-386
Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora
Edlund C; Sjostedt S; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1996;38(6):927-939
Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection
Stark CA; Adamsson I; Edlund C; Sjosted S; Seensalu R; Wikstrom B; Nord CE
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1996;85(9):1126-1128
Oral IgA-IgG treatment of chronic non-specific diarrhoea in infants and children
Casswall TH; Hammarstrom L; Veress B; Nord CE; Bogstedt A; Brockstedt U; Dahlstrom KA
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 1996;15(8):646-649
Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction
Hall G; Heimdahl A; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 1996;22(6):944-950
Resistance of the normal human microflora to mercury and antimicrobials after exposure to mercury from dental amalgam fillings
Edlund C; Bjorkman L; Ekstrand J; SandborghEnglund G; Nord CE
Article: ANAEROBE. 1996;2(2):111-115
The role of penicillin-binding proteins for beta-lactam resistance in a beta-lactamase producing Bacteroides uniformis strain
Hedberg M; Bush K; Bradford PA; Bhachech N; Edlund C; Tuner K; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1996;37(4):783-795
Elimination of bacteraemia after dental extraction: Comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis
Hall G; Nord CE; Heimdahl A
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1996;28(5):507-512
Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
Article: ACTA OTO-LARYNGOLOGICA. 1995;115(5):689-696
UP-REGULATED LOCAL CYTOKINE PRODUCTION IN RECURRENT TONSILLITIS COMPARED WITH TONSILLAR HYPERTROPHY
AGREN K; ANDERSSON U; NORDLANDER B; NORD CE; LINDE A; ERNBERG I; ANDERSSON J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1995;39(7):1458-1461
PURIFICATION AND CHARACTERIZATION OF A NEW BETA-LACTAMASE FROM BACTEROIDES UNIFORMIS
HEDBERG M; LINDQVIST L; BERGMAN T; NORD CE
Article: JOURNAL OF INFECTIOUS DISEASES. 1995;171(5):1230-1236
DEVELOPMENT AND CHARACTERIZATION OF A NEW MODEL OF HEMATOGENOUS OSTEOMYELITIS IN THE RAT
HIENZ SA; SAKAMOTO H; FLOCK JI; MORNER AC; REINHOLT FP; HEIMDAHL A; NORD CE
Article: AMERICAN JOURNAL OF SURGERY. 1995;169(5A):S21-S26
CLINICAL-TRIALS OF EXTENDED-SPECTRUM PENICILLIN/BETA-LACTAMASE INHIBITORS IN THE TREATMENT OF INTRAABDOMINAL INFECTIONS - EUROPEAN AND NORTH-AMERICAN EXPERIENCE
WILSON SE; NORD CE
Article: DRUGS. 1995;49 Suppl 2:233-234
In vitro activity of new quinolones against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1995;35(1):139-148
Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
Article: INFECTIOUS DISEASES IN CLINICAL PRACTICE. 1995;4:S17-S25
TREATMENT OF INTRAABDOMINAL INFECTIONS - WORLDWIDE CLINICAL-TRIALS
NORD CE
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 1995;14(1):18-24
INDUCTION OF BETA-LACTAMASE BY CEFOXITIN IN ANAEROBIC INTESTINAL MICROFLORA
STARK C; EDLUND C; HEDBERG M; NORD CE
Show more

All other publications

Review: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(8):4257-4263
Alternative Strategies for Proof-of-Principle Studies of Antibacterial Agents
Dalhoff A; Weintraub A; Nord CE
Published conference paper: ANAEROBE. 2013;24:107-108
What is hot in the anaerobe literature? Clostridium difficile infections
Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;34(6):516-522
Antimicrobial resistance in Clostridium difficile
Huang H; Weintraub A; Fang H; Nord CE
Letter: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;33(4):386-387
Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit in Leon, Nicaragua
Amaya E; Caceres M; Fang H; Torres Ramirez A; Palmgren AC; Nord CE; Weintraub A
Letter: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(2):158-159
Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain
Huang H; Weintraub A; Fang H; Nord CE
Letter: CLINICAL INFECTIOUS DISEASES. 2008;47(12):1606-1608
Molecular and Clinical Characteristics of Clostridium difficile Infection in a University Hospital in Shanghai, China
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren A-C; Weintraub A; Nord CE
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2008;12:E39
Antimicrobial Resistance Among Anaerobes - The European Experience
Nord CE
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2008;12:E451
Epidemiological Characterization of Clostridium difficile Strains in Shanghai, China
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2008;12:E22
Diagnosing Clostridium difficile-Associated Diseases: The State of the Art
Nord CE
Published conference paper: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2008;32(5):374-377
Virulence and antimicrobial resistance in clinical Enterococcus faecium
Billstrom H; Lunda B; Sullivan A; Nord CE
Letter: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2007;42(12):1514-1515
Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness
Evengard B; Grans H; Wahlund E; Nord CE
Letter: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2006;10(6):482-483
Emergence of methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin gene in Shanghai, China
Li G-H; Zhang Y-Y; Wang F; Chen Y-J; Nord CE; Fang H
Review: ANAEROBE. 2006;12(5-6):207-210
Antibiotic resistance in Propionibacterium acnes.: Microbiological and clinical aspects
Nord CE; Oprica C
Published conference paper: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2006;28(4):292-296
Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes
Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
Editorial comment: THE LANCET INFECTIOUS DISEASES. 2005;5(2):115-119
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby SR; Nord CE; Finch R
Review: JOURNAL OF INTERNAL MEDICINE. 2005;257(1):78-92
Probiotics and gastrointestinal diseases
Sullivan Å; Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2002;20(5):313-319
The place of probiotics in human intestinal infections
Sullivan Å; Nord CE
Editorial comment: DRUGS. 2002;62(15):2235
Biapenem - A viewpoint by Carl Erik Nord
Nord CE
Published conference paper: CLINICAL INFECTIOUS DISEASES. 2002;35(Suppl 1):S47-S53
Selection of cefoxitin-resistant Bacteroides thetaiotaomicron mutants and mechanisms involved in β-lactam resistance
Fang H; Edlund C; Nord CE; Hedberg M
Review: DERMATOLOGY NURSING / DERMATOLOGY NURSES' ASSOCIATION. 2002;14(4):242-246
Overview of treatments for acne.
Oprica C; Emtestam L; Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2002;19(5):361-370
New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group
Fang H; Edlund C; Hedberg M; Nord CE
Review: THE LANCET INFECTIOUS DISEASES. 2001;1(2):101-114
Effect of antimicrobial agents on the ecological balance of human microflora.
Sullivan A; Edlund C; Nord CE
Published conference paper: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2001;7:37-41
The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trials
Edlund C; Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2000;16(3):191-197
Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem
van der Waaij D; Nord CE
Published conference paper: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2000;46:41-48
Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections
Edlund C; Nord CE
Review: JOURNAL OF CHEMOTHERAPY. 2000;12(1):5-16
Microbial ecology and treatment of Helicobacter pylori infections:: Review
Adamsson I; Edlund C; Nord CE
Review: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH. 2000;26(3):95-111
Bifidobacteria and lactobacilli in human health
Orrhage K; Nord CE
Published conference paper: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS, SUPPLEMENT. 1999;88(430):47-57
Factors controlling the bacterial colonization of the intestine in breastfed infants
Orrhage K; Nord CE
Review: INFECTION. 1999;27(3):166-172
Use of newer quinolones for the treatment of intraabdominal infections: Focus on clinafloxacin
Nord CE
Review: INFECTION. 1999;27(2):136-147
Monobactams and carbapenems for treatment of intraabdominal infections.
Brismar B; Nord CE
Published conference paper: DRUGS. 1999;58:65-70
Effect of quinolones on intestinal ecology
Edlund C; Nord CE
Published conference paper: CLINICAL INFECTIOUS DISEASES. 1998;27(3):471-473
Entamoeba gingivalis in human immunodeficiency virus type 1-infected patients with periodontal disease
Lucht E; Evengård B; Skott J; Pehrson P; Nord CE
Published conference paper: CLINICAL INFECTIOUS DISEASES. 1997;25:S270-S271
Role of penicillin-binding proteins in resistance of Bacteroides fragilis group species to beta-lactam drugs
Hedberg M; Nagy E; Nord CE
Editorial comment: INFECTION. 1997;25(4):195-196
Ecological aspects of antimicrobial treatment of Helicobacter pylori infections
Einarsson C; Nord CE
Published conference paper: CLINICAL INFECTIOUS DISEASES. 1996;23:S15-S18
In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria
Nord CE
Review: JOURNAL OF CHEMOTHERAPY. 1996;8(5):331-341
Antimicrobial treatment of periodontal diseases disturbs the human ecology: A review
Edlund C; Hedberg M; Nord CE
Review: ZENTRALBLATT F�R BAKTERIOLOGIE : INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY. 1996;283(4):431-465
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; An overview of current literature
Araneo BA; Cebra JJ; Beuth J; Fuller R; Heidt PJ; Midvedt T; Nord CE; Nieuwenhuis P; Manson WL; Pulverer G; Rusch VC; Tanaka R; vanderWaaij D; Walker RI; Wells CL
Review: JOURNAL OF CHEMOTHERAPY. 1996;8(1):3-16
Beta-lactam resistance in anaerobic bacteria: A review
Hedberg M; Nord CE
Published conference paper: MEDICAL MICROBIOLOGY LETTERS. 1996;5(6):295-304
Antimicrobial-resistant anaerobic bacteria in human infections
Hedberg M; Nord CE
Letter: BRITISH JOURNAL OF RHEUMATOLOGY. 1995;34(11):1095-1096
Lymphocyte reactivity to Clostridium perfringens antigens and toxoid in patients with arthritis
Strom H; Borg AJ; Nord CE; Olhagen B; Moller E
Published conference paper: CLINICAL INFECTIOUS DISEASES. 1995;20:S350-S351
INDUCTION OF BETA-LACTAMASE PRODUCTION IN THE ANAEROBIC MICROFLORA BY CEFOXITIN
STARK C; EDLUND C; HEDBERG M; NORD CE
Review: CLINICAL INFECTIOUS DISEASES. 1995;20(6):1512-1524
THE ROLE OF ANAEROBIC-BACTERIA IN RECURRENT EPISODES OF SINUSITIS AND TONSILLITIS
NORD CE
Review: DRUG SAFETY. 1995;12(5):305-313
ADVERSE-EFFECTS OF MONOBACTAMS AND CARBAPENEMS
ALVAN G; NORD CE
Meeting abstract: GASTROENTEROLOGY. 1995;108(4):A792
ORAL IGA TREATMENT OF CHRONIC NONSPECIFIC DIARRHEA IN INFANTS AND CHILDREN
CASSWALL TH; HAMMARSTROM L; BOGSTEDT A; NORD CE; VERESS B; BROCKSTEDT U; DAHLSTROM KA
Published conference paper: JOURNAL OF CHEMOTHERAPY. 1995;7(1):42-44
BIAPENEM VERSUS IMIPENEM IN THE TREATMENT OF EXPERIMENTAL INTRAABDOMINAL INFECTIONS
NORD CE; LAHNBORG G
Review: DRUGS. 1995;49 Suppl 2:81-85
Effect of quinolones on the human intestinal microflora.
Nord CE
Editorial comment: MICROBIAL DRUG RESISTANCE. 1995;1(2):101
Antibiotic Resistance in Respiratory Tract Pathogens: Clinical and Therapeutic Consequences - Proceedings of a Symposium held at the Swedish Society of Medicine, Stockholm, Sweden, October 31 November 1, 1994 - Foreword
Nord CE
Other: INFECTION. 1995;23(1):51-54
ORAL-ADMINISTRATION OF A CERTAIN STRAIN OF LIVE ESCHERICHIA-COLI FOR INTESTINAL DISORDERS - ARTIFICIAL CONTAMINATION AND MANIPULATION OF THE DIGESTIVE-TRACT - OUR POOR GIT
MARGET W; BEUTIN L; SEELIGER H; WINBERG J; VANDERWAAIJ D; NORD CE
Other: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 1995;14(1):61-64
LACK OF EFFECT OF ORALLY-ADMINISTERED HUMAN SERUM IMMUNOGLOBULIN ON THE NORMAL HUMAN ORAL AND INTESTINAL MICROFLORA
BOGSTEDT AK; NORD CE; HAMMARSTROM L
Show more

Articles

All other publications

News from KI

Events from KI